Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Emerging Microbes & Infections|June 28, 2021
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2Carla Saade, Claudia Gonzalez, Antonin Bal, et al.
Iscience|April 14, 2025
BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individualsCarla Saade, Timothée Bruel, Lou-Léna Vrignaud, et al.
The Lancet Regional Health. Europe|July 19, 2021
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in FranceTiffany Charmet, Laura Schaeffer, Rebecca Grant, et al.
Scientific Reports|July 23, 2021
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort studyAntonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Virological and clinical features of acute respiratory failure associated with COVID-19 in pregnancy: a case-control studyJean-Christophe Richard, Emilie Frobert, Grégory Destras, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 23, 2021
Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, FranceJean-Sebastien Casalegno, Dominique Ploin, Aymeric Cantais, et al.
Emerging Microbes & Infections|September 13, 2022
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infectionsCarla Saade, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2020
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020Kostas Danis, Olivier Epaulard, Thomas Bénet, et al.
The Journal of Experimental Medicine|August 6, 2021
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJonathan Lopez, Marine Mommert, William Mouton, et al.
The Lancet. Infectious Diseases|April 1, 2020
Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesFrancois-Xavier Lescure, Lila Bouadma, Duc Nguyen, et al.
Pageof 26